ALLIANCE PHARMA PLC — Major Shareholding Notification 2015

Sep 2, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9166X

Alliance Pharma PLC

02 September 2015

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			ALLIANCE PHARMA PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:		NIGEL WRAY
4. Full name of shareholder(s)  (if different from 3.):		PERSHING NOMINEES LIMITED      ROY NOMINEES LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached:		28th August 2015
6. Date on which issuer notified:		1st September 2015
7. Threshold(s) that is/are crossed or reached:		14%

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of  voting rights
Direct		Direct		Indirect	Direct			Indirect
Ordinary shares GB0031030819	40,176,510			40,176,510			15,511,922		15,511,922		22,164,588	5.86%			8.38%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date		Exercise/ Conversion Period					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date		Exercise/ Conversion period			Number of voting rights instrument refers to				% of voting rights
													Nominal			Delta
Total (A+B+C)
Number of voting rights								Percentage of voting rights
37,676,510								14.24%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Nigel William Wray has a beneficial interest in shares in Alliance Pharma Plc held by the following nominees Pershing Nominees Limited 15,511,922 The family of Nigel Wray maintains a beneficial interest in the shares held by Roy Nominees Limited   - 22,164,588
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Figures are based on a total number of voting rights of 264,080,873
14. Contact name:	Nigel Wray
15. Contact telephone number:	020 7647 7647

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAXNAEEESEFF

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'HEnSlv0kyXQD9_UuSORB6eNCxFPQj1WeWjibD0CL6WC12TBs-GvU-vRVz6ucYdLwnwNLyhrWvxr82UmotD1z2CCbD99P8Z4Ltim5sKQD3Qc1:NKSYcIxzVvG7G0_v4SHBJC66aAkQ8oU_fMal1LB6lCUsmtPUV7pwcRx7h1pnNc589KdrI7JZDqXgk4qHVVo8ftgkL8HfAcZ0CfTWfsrB7VM1'}});//]]>